Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons

B J Wilcox1, M D Applegate, C Portera-Cailliau

  • 1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, Maryland 21205, USA.

Insights

Nerve Growth Factor (NGF) prevents cell death in injured central cholinergic neurons by inhibiting apoptosis. This study confirms NGF

Area of Science:

  • Neuroscience
  • Cell Biology

Background:

  • Experimental lesions are used to study neuronal degeneration and trophic molecule effects.
  • Previous studies lacked definitive proof of lesion-induced neuronal death.

Purpose of the Study:

  • To investigate retrograde neuronal changes in medial septal nucleus (MSN) cholinergic neurons after fimbria-fornix (F-F) transection.
  • To determine the timing and mechanism of neuronal death.
  • To assess the neuroprotective effect of Nerve Growth Factor (NGF).

Main Methods:

  • Combined Fluoro-gold (FG) labeling, choline acetyltransferase (ChAT) immunohistochemistry, electron microscopy (EM), and TUNEL assay.
  • Quantified FG-labeled and ChAT-immunoreactive neurons at multiple time points post-lesion.
  • Administered intraventricular NGF to a subset of animals.

Main Results:

  • Neuronal death in MSN cholinergic neurons occurred via apoptosis, starting at 16 days postaxotomy.
  • Approximately 50% of neurons disappeared between weeks 3 and 4 post-lesion.
  • NGF treatment prevented the degeneration of the majority of cholinergic neurons.

Conclusions:

  • NGF administration significantly prevents cell death in lesioned central cholinergic neurons.
  • NGF's protective effect extends beyond phenotypic preservation to include the prevention of apoptosis.
  • This study provides critical data on the timing of neuronal death and the efficacy of NGF in a central nervous system injury model.